trimetazidine has been researched along with Ventricular Dysfunction, Left in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.23) | 18.2507 |
| 2000's | 26 (83.87) | 29.6817 |
| 2010's | 2 (6.45) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Bahrudin, U; Harjoko, RP; Herminingsih, S; Maharani, N; Sobirin, MA; Tsutsui, H; Uddin, I | 1 |
| Bilovol, O; Dunaieva, I; Kiriienko, O; Knyazkova, I | 1 |
| Ding, WY; Li, Y; Tang, MX; Wang, F; Wang, ZH; Zhang, L; Zhang, W; Zhang, Y; Zhong, M | 1 |
| Belardinelli, R; Faccenda, E; Lacalaprice, F; Volpe, L | 1 |
| Akdag, S; Gumrukcuoglu, HA; Gunes, Y; Guntekin, U; Tuncer, M | 1 |
| Tang, WH | 1 |
| Cera, M; Fragasso, G; Margonato, A; Montanaro, C; Salerno, A; Spoladore, R | 1 |
| Caminiti, G; Fini, M; Gebara, O; Marazzi, G; Ramires, JA; Rosano, G; Vitale, C; Volterrani, M; Wajngarten, M | 1 |
| Domergue-Dupont, V; Grynberg, A; Liao, R; Mouquet, F; Rousseau, D | 1 |
| Kaliuzhin, VV; Kamaev, DIu; Solovtsov, MA; Tepliakov, AT | 1 |
| Aleksandriia, LG; Moiseev, VS; Tereshchenko, SN | 1 |
| Marzilli, M; Stanley, WC | 1 |
| Drobotia, NV; Eroshenko, OL; Kastanaian, AA; Kazarian, NB; Nelasov, NIu | 1 |
| Biggi, A; Feola, M; Ferrero, V; Francini, A; Leonardi, G; Ribichini, F; Uslenghi, E | 2 |
| Belardinelli, R | 2 |
| Fini, M; Gebara, O; Rosano, GM; Rossini, P; Sposato, B; Vitale, C; Volterrani, M; Wajngaten, M | 1 |
| Barsotti, A; Di Napoli, P; Taccardi, AA | 1 |
| Biggi, A; Feola, M; Francini, A; Leonardi, G; Ribichini, F; Uslenghi, E; Vado, A | 1 |
| Calori, G; De Cobelli, F; Del Maschio, A; Esposito, A; Fragasso, G; Lattuada, G; Margonato, A; Palloshi, A; Perseghin, G; Scifo, P | 1 |
| Jackson, G | 1 |
| Iushchuk, EN; Khadzegova, AB; Sadulaeva, IA; Shkol'nik, EL; Vakhromeeva, MN; Vasiuk, IuA; Vit'ko, NK | 1 |
| Baiandin, NL; Gordeev, IG; Il'ina, EE; Kuznechevskiĭ, FV; Liusov, VA | 1 |
| Fragakis, N; Giannoglou, G; Katsaris, G; Labrou, A; Louridas, G; Zioutas, D | 1 |
| Chierchia, SL; Dabrowski, P; Fragasso, G; Lu, C | 1 |
| Marzilli, M | 1 |
| Chierchia, SL | 1 |
| Kuznetsova, GV; Samarskaia, GN; Shelepova, NV; Shpagina, LA; Tret'iakov, SV; Zheliasniak, MS | 1 |
| Belardinelli, R; Purcaro, A | 1 |
6 review(s) available for trimetazidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
The metabolic approach in patients with heart failure: effects on left ventricle remodeling.
Topics: Glucagon-Like Peptide 1; Heart Failure; Humans; Risk Assessment; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2009 |
Effects of metabolic approach in diabetic patients with coronary artery disease.
Topics: Acetyl-CoA C-Acyltransferase; Carnitine O-Palmitoyltransferase; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Humans; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
Topics: Angina Pectoris; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus; Energy Metabolism; Fatty Acids; Humans; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
[Ischemic heart disease and left ventricular dysfunction: the role of trimetazidine].
Topics: Clinical Trials as Topic; Humans; Myocardial Ischemia; Trimetazidine; Ventricular Dysfunction, Left | 2004 |
Clinical benefits of a metabolic approach in the management of coronary patients.
Topics: Coronary Disease; Diabetes Complications; Drug Therapy, Combination; Humans; Myocardial Reperfusion; Trimetazidine; Ventricular Dysfunction, Left | 2000 |
Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Topics: Humans; Myocardial Contraction; Myocardial Ischemia; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2000 |
17 trial(s) available for trimetazidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Trimetazidine improves left ventricular global longitudinal strain value in patients with heart failure with reduced ejection fraction due to ischemic heart disease.
Topics: Aged; Heart Failure; Humans; Middle Aged; Myocardial Ischemia; Stroke Volume; Trimetazidine; Ventricular Dysfunction, Left | 2022 |
Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
Topics: Aged; Biomarkers; Blood Pressure; Body Mass Index; Brachial Artery; Cardiomyopathies; Combined Modality Therapy; Echocardiography, Doppler, Pulsed; Electrocardiography; Exercise Test; Exercise Therapy; Female; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Stroke Volume; Time Factors; Treatment Outcome; Trimetazidine; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left | 2008 |
The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
Topics: Chemotherapy, Adjuvant; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Quality of Life; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
[Effect of atenolol and trimetazidine on dispersion of cardiac rhythm in patients with moderately expressed postinfarction left ventricular dysfunction].
Topics: Anti-Arrhythmia Agents; Atenolol; Humans; Myocardial Infarction; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2002 |
[Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Diuretics; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Female; Fibrinolytic Agents; Follow-Up Studies; Hemodynamics; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2002 |
[Effect of acetyl-CoA C-acyltransferase inhibitor trimetazidine on parameters of global and local systolic and diastolic functions of left ventricular myocardium in patients with combined postinfarction ischemic syndrome].
Topics: Acetyl-CoA C-Acyltransferase; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Syndrome; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
Topics: Aged; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Quality of Life; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2004 |
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.
Topics: Aged; Analysis of Variance; Anti-Inflammatory Agents; C-Reactive Protein; Cardiomyopathy, Dilated; Female; Humans; Long-Term Care; Male; Pilot Projects; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
[Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Female; Humans; Male; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Coronary Angiography; Coronary Artery Disease; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Double-Blind Method; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Magnetic Resonance Angiography; Male; Phosphocreatine; Prospective Studies; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
[Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Diuretics; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Methylhydrazines; Middle Aged; Positron-Emission Tomography; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
Topics: Acute Disease; Administration, Oral; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Creatine Kinase, MB Form; Echocardiography; Female; Heart Ventricles; Humans; Hypokinesia; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardial Revascularization; Premedication; Syndrome; Trimetazidine; Troponin I; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease.
Topics: Administration, Oral; Coronary Disease; Cross-Over Studies; Dobutamine; Drug Administration Schedule; Echocardiography; Female; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 1998 |
Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease.
Topics: Aged; Cardiotonic Agents; Coronary Disease; Cross-Over Studies; Dobutamine; Double-Blind Method; Exercise Test; Female; Humans; Male; Middle Aged; Trimetazidine; Ultrasonography; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy.
Topics: Analysis of Variance; Cardiomyopathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2001 |
8 other study(ies) available for trimetazidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
PARAMETERS OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH HYPERTENSION DISEASE WITH CONCOMITANT TYPE 2 DIABETES.
Topics: Diabetes Mellitus, Type 2; Eplerenone; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Trimetazidine; Ventricular Dysfunction, Left | 2023 |
Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy.
Topics: Adenylate Kinase; Animals; Apoptosis; Autophagy; Blood Glucose; Catheterization; Collagen; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Disease Models, Animal; Fibrosis; Glucose Intolerance; Insulin; Male; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction; Trimetazidine; Ventricular Dysfunction, Left | 2016 |
Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat.
Topics: Animals; Data Interpretation, Statistical; Disease Models, Animal; Fatty Acids; Male; Myocardial Infarction; Myocardial Reperfusion; Oxidation-Reduction; Rats; Rats, Wistar; Survival Analysis; Trimetazidine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction.
Topics: Aged; Coronary Artery Disease; Coronary Vessels; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Male; Myocardial Infarction; Myocardial Ischemia; Single-Blind Method; Stroke Volume; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2004 |
The acute administration of trimetazidine modified myocardial perfusion and left ventricular function in 31 patients with ischaemic ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Coronary Angiography; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Radiopharmaceuticals; Stroke Volume; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left | 2004 |
Metabolic approach to heart failure - evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis.
Topics: Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
[Derangements of contractility of left ventricular myocardium in patients subjected to coronary bypass surgery. Methods of their correction].
Topics: Adult; Aged; Angina Pectoris; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Contraction; Postoperative Complications; Trimetazidine; Ventricular Dysfunction, Left | 2007 |
[Aspects of diastolic function of the heart in vibration disease].
Topics: Data Interpretation, Statistical; Diastole; Echocardiography, Doppler; Follow-Up Studies; Humans; Male; Middle Aged; Occupational Diseases; Time Factors; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right; Vibration | 2001 |